Advanced practice nurse management in multiple myeloma treated with oral therapy

被引:3
作者
Sapet, Manon [1 ,4 ]
Migala, Cecile [2 ]
Daguenet, Elisabeth [3 ]
Collet, Philippe [3 ]
Boussoualim, Karima [1 ]
Thomas, Thierry [1 ]
Guyotat, Denis [3 ]
Augeul-Meunier, Karine [3 ]
机构
[1] Univ Hosp St Etienne, Dept Rheumatol, F-42055 St Etienne 2, France
[2] Canc Inst Lucien Neuwirth, Coordinat Platform, St Priest En Jarez, France
[3] Canc Inst Lucien Neuwirth, Hematol Dept, St Priest En Jarez, France
[4] CHU St Etienne, Dept Rheumatol, F-42055 St Etienne 2, France
关键词
Advanced practice nurse; Multiple myeloma; Oral chemotherapy; Safety monitoring; Side-effect management; Remote follow-up; LENALIDOMIDE PLUS DEXAMETHASONE; LED FOLLOW-UP; MEDICATION ADHERENCE; ANTICANCER AGENTS; LUNG-CANCER; INTERVENTION; CHEMOTHERAPY; PERCEPTIONS; FRAMEWORK; SAFETY;
D O I
10.1016/j.bulcan.2023.07.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction > Therapeutic approaches in Multiple Myeloma (MM) have considerably changed over the last few years, with effective oral chemotherapy and continuous treatment. In this context, the objective of this study was to examine the circuitry of an advanced practitioner nurse (APN)-led intervention that provided supportive care for MM patients treated with oral chemotherapy.Methods > This population-based study was conducted at the hematology department - Institut de Cancerologie Lucien Neuwirth (ICLN, Saint-Priest-en-Jarez), from April 2017 to September 2020. A follow-up program was established with a specialized APN in oncology. Results > All APN interventions were recorded, representing 1240 phone calls and 162 consulta-tions for 42 MM patients. Eighty-two calls were referred to the physician with 45 consultations triggered. Most of the calls were frequent within the few first months, with a high request for information and reassurance, especially for treatment-naive or relapsed patients. In our study, the APN was able to manage multiple side effects through care organization (i.e., hospitalizations, transfusions) and a careful coordination between the primary care team and the hospital.Discussion > In order to respond to the high need for care pathway and safety improvement, especially in elderly population, we have initiated an original follow-up by an APN for MM patients treated with oral chemotherapy. While the role of APN has become prominent in the oncology field in recent years, its holistic approach has to be emphasized in further studies to bring a compre-hensive perspective to health care coordination in the future.
引用
收藏
页码:1251 / 1259
页数:9
相关论文
共 35 条
  • [31] Overview of the Challenges Related to Oral Agents for Cancer and Their Impact on Adherence
    Tipton, Janelle M.
    [J]. CLINICAL JOURNAL OF ONCOLOGY NURSING, 2015, 19 (03) : 37 - 40
  • [32] Tokdemir G, 2017, ASIA-PAC J ONCOL NUR, V4, P290, DOI 10.4103/apjon.apjon_35_17
  • [33] Rapidly changing myeloma epidemiology in the general population: Increased incidence, older patients, and longer survival
    Turesson, Ingemar
    Bjorkholm, Magnus
    Blimark, Cecilie Hveding
    Kristinsson, Sigurdur
    Velez, Ramon
    Landgren, Ola
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (02) : 237 - 244
  • [34] Adherence to oral anticancer agents: Healthcare providers' perceptions, beliefs and shared decision making in Belgium and the Netherlands
    Verbrugghe, Mathieu
    Timmers, Lonneke
    Boons, Christel C. L. M.
    Van Den Bemt, Bart J. F.
    Hugtenburg, Jacqueline G.
    Van Hecke, Ann
    [J]. ACTA ONCOLOGICA, 2016, 55 (04) : 437 - 443
  • [35] Inner conflict in patients receiving oral anticancer agents: a qualitative study
    Yagasaki, Kaori
    Komatsu, Hiroko
    Takahashi, Tsunehiro
    [J]. BMJ OPEN, 2015, 5 (04):